Delivering value through Exyte’s EPC and EPCM models

Exyte’s Global Business Unit Biopharma and Life Sciences (BLS) plays a pivotal role in advancing partnerships and innovation in pharmaceutical, biotechnology, and life sciences industries. By delivering high-performance and high-tech facilities, BLS helps shape the future of medicine and manufacturing.] Central to this capability are two project delivery models: Engineering, Procurement, and Construction (EPC) and Engineering, Procurement, and Construction Management (EPCM), each offering strategic value tailored to unique client requirements. In this article, Padraig Finn, Exyte Senior Vice President of Business Acquisition BLS, explains the benefits of Exyte’s flexible project delivery approach.


 

EPC offers integrated solutions with reduced client burden

The EPC approach distinguishes Exyte within the life sciences sector, particularly for large-scale investment projects that require fixed costs, timely completion, and single-point accountability. The EPC model provides clients with a fully integrated solution. Exyte assumes complete responsibility for the design, procurement, and construction of a facility, making it highly beneficial for clients dealing with tight timelines, complex projects, or limited internal resources. This model ensures certainty, rapid project delivery, and significantly reduces the burden on client teams.

“Our EPC model is designed to offer predictability and efficiency, especially in environments where schedules are tight and complexity is high,” says Finn. “By taking full responsibility for execution, we help clients focus on their core business while we ensure that project goals are met,”

"EPCM allows Exyte to work with clients to shape solutions that reflect their goals”

In contrast, the EPCM model allows for greater client involvement, flexibility, and ongoing collaboration throughout project execution. Under EPCM, Exyte oversees the design and construction management, while clients retain control over selecting contractors and procuring construction services.

“EPCM enables clients to remain actively involved in decision-making, which is particularly valuable in projects with evolving scopes or specialized requirements,” Finn explains. “It provides the flexibility to adapt during project execution while benefiting from our technical leadership and project management expertise.” He adds that EPCM is often suited to clients with experienced internal teams or phased implementation strategies. The model supports open communication, collaborative planning, and shared accountability. “This approach allows us to work closely with clients to shape solutions that reflect their goals,” says Finn. “It supports long-term partnerships built on trust, transparency, and mutual success.”

Exyte’s experience delivering both EPC and EPCM projects across the life sciences sector enables project teams to adapt to a wide range of client needs. By offering flexibility in delivery models, Exyte supports clients in achieving their project objectives efficiently, reliably, and with a shared focus on quality.

To learn more about how Exyte can support your next biopharma and life sciences project, get in touch with our team today.